Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.01B |
| 2 |
Apple
AAPL
|
+$658M |
| 3 |
Microsoft
MSFT
|
+$498M |
| 4 |
SPDR Gold Trust
GLD
|
+$432M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$299M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$464M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$444M |
| 3 |
Alibaba
BABA
|
+$401M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 5 |
RTX Corp
RTX
|
+$273M |
Sector Composition
| 1 | Technology | 15.78% |
| 2 | Financials | 12.23% |
| 3 | Healthcare | 11.25% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEOS
3076
DELISTED
Neos Therapeutics, Inc
NEOS
| $100K | ﹤0.01% |
12,003
+6,277
| +110% | +$52.3K |
|
|
SUP
3077
DELISTED
Superior Industries International
SUP
| $99K | ﹤0.01% |
7,430
+3,272
| +79% | +$43.6K |
|
|
TVRD
3078
Tvardi Therapeutics, Inc. Common Stock
TVRD
$366M
| $99K | ﹤0.01% |
225
-329
| -59% | -$145K |
|
3079
Adecoagro
AGRO
$817M
| $98K | ﹤0.01% |
13,063
+5,988
| +85% | +$44.9K |
|
3080
Codexis
CDXS
$212M
| $98K | ﹤0.01% |
8,904
+2,434
| +38% | +$26.8K |
|
3081
National Research Corp
NRC
$367M
| $98K | ﹤0.01% |
3,352
+1,673
| +100% | +$48.9K |
|
3082
B. Riley Financial
RILY
$230M
| $98K | ﹤0.01% |
5,027
+690
| +16% | +$13.5K |
|
3083
Victory Capital Holdings
VCTR
$4.49B
| $98K | ﹤0.01% |
+7,948
| New | +$98K |
|
|
ANH
3084
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $98K | ﹤0.01% |
20,287
+4,857
| +31% | +$23.5K |
|
3085
Celldex Therapeutics
CLDX
$1.62B
| $97K | ﹤0.01% |
2,790
+1,399
| +101% | +$48.6K |
|
3086
Franklin Covey
FC
$244M
| $97K | ﹤0.01% |
3,605
+1,179
| +49% | +$31.7K |
|
3087
Morningstar
MORN
$10.5B
| $97K | ﹤0.01% |
1,016
-1,555
| -60% | -$148K |
|
|
NVEE
3088
DELISTED
NV5 Global
NVEE
| $97K | ﹤0.01% |
6,988
+1,712
| +32% | +$23.8K |
|
3089
SPDR S&P Dividend ETF
SDY
$20.3B
| $97K | ﹤0.01% |
1,068
+1,000
| +1,471% | +$90.8K |
|
|
TTPH
3090
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $97K | ﹤0.01% |
1,575
-1,897
| -55% | -$117K |
|
3091
Invesco CurrencyShares Swiss Franc Trust
FXF
$382M
| $96K | ﹤0.01% |
+980
| New | +$96K |
|
3092
Galectin Therapeutics
GALT
$294M
| $96K | ﹤0.01% |
+20,123
| New | +$96K |
|
3093
iShares US Aerospace & Defense ETF
ITA
$9.25B
| $96K | ﹤0.01% |
972
| – | – |
|
3094
Northeast Bank
NBN
$935M
| $96K | ﹤0.01% |
4,648
+65
| +1% | +$1.34K |
|
|
HTB
3095
HomeTrust Bancshares, Inc.
HTB
$716M
| $96K | ﹤0.01% |
3,675
+1,030
| +39% | +$26.9K |
|
3096
Addus HomeCare
ADUS
$1.99B
| $95K | ﹤0.01% |
1,941
+679
| +54% | +$33.2K |
|
3097
FS KKR Capital
FSK
$4.49B
| $95K | ﹤0.01% |
+3,263
| New | +$95K |
|
3098
Harmonic Inc
HLIT
$1.14B
| $94K | ﹤0.01% |
25,031
+4,551
| +22% | +$17.1K |
|
3099
Ribbon Communications
RBBN
$682M
| $94K | ﹤0.01% |
18,317
+4,721
| +35% | +$24.2K |
|
|
ABTX
3100
DELISTED
Allegiance Bancshares, Inc.
ABTX
| $94K | ﹤0.01% |
2,402
+569
| +31% | +$22.3K |
|